Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Subcutaneous opioid infusions at home

N Coyle1, N I Cherny, R K Portenoy

  • 1Department of Neurology, Memorial Sloan-Kettering Cancer Center.

Oncology (Williston Park, N.Y.)
|April 1, 1994
PubMed
Summary

Home subcutaneous infusions significantly improve cancer patient care, especially for long-term opioid pain management. Successful treatment requires careful planning of patient selection, infusion details, and healthcare resources.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) visualisation: picturing the evidence of clinical benefit of clinical trial data.

ESMO real world data and digital oncology·2026
Same author

ESMO-Magnitude of Clinical Benefit Scale version 2.0 (ESMO-MCBS v2.0).

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

ESMO Global Consortium Study on the availability, out-of-pocket costs, and accessibility of cancer medicines: 2023 update.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

A taxonomy of the factors contributing to the overtreatment of cancer patients at the end of life. What is the problem? Why does it happen? How can it be addressed?

ESMO open·2025
Same author

Improvements in Survival and Clinical Benefit With Gemcitabine as First-Line Therapy for Patients With Advanced Pancreas Cancer: A Randomized Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023
Same author

Essential cancer medicines: adding feasibility to the magnitude of clinical benefit value chain.

ESMO open·2023

Area of Science:

  • Oncology
  • Palliative Care
  • Pharmacology

Background:

  • Home-based subcutaneous infusions have transformed patient care.
  • A primary use in oncology is prolonged parenteral opioid administration.
  • Effective home infusion requires comprehensive planning.

Purpose of the Study:

  • To highlight the critical factors for successful home subcutaneous infusion in cancer patients.
  • To emphasize the importance of multidisciplinary collaboration in long-term management.

Main Methods:

  • Review of key considerations for initiating home subcutaneous infusions.
  • Discussion of essential elements for ongoing patient management.
  • Emphasis on patient selection, pump and drug choice, infusion parameters, and healthcare system resources.

Main Results:

  • Successful home infusion hinges on meticulous patient selection.
  • Optimizing pump, drug, infusion mode, and dosing is crucial.
  • Availability of family, community healthcare, and insurance coverage are vital factors.

Conclusions:

  • Home subcutaneous infusions offer a significant benefit for cancer patients requiring long-term opioid therapy.
  • Proactive planning encompassing patient, drug, device, and resource assessment is essential for success.
  • Sustained collaboration between hospital teams, home care agencies, and community providers ensures effective long-term management.

Related Experiment Videos